Prediction of mortality in neonates with congenital diaphragmatic hernia treated with extracorporeal membrane oxygenation.

OBJECTIVE To determine if data collected by the Extracorporeal Life Support Organization Registry could be used to identify neonates with congenital diaphragmatic hernia who had a > 90% mortality rate, despite the use of extracorporeal membrane oxygenation (ECMO) support. DESIGN We retrospectively reviewed data reported to the Extracorporeal Life Support Organization Registry on neonates with congenital diaphragmatic hernia. PATIENTS Data regarding 1,089 neonates with congenital diaphragmatic hernia reported to the Extracorporeal Life Support Organization Registry between 1980 and 1992 formed the basis of this study. All of the neonates studied had been treated with ECMO. This patient population includes neonates with right- and left-sided diaphragmatic hernia. This registry does not include neonates with congenital diaphragmatic hernia who were not treated with ECMO. MEASUREMENTS AND MAIN RESULTS Of 1,089 neonates with congenital diaphragmatic hernia, 679 (62%) survived. There were no differences between the two groups in gender or in the year they were treated. Survival rate did not significantly increase over the years between 1980 and 1992. When compared with survivors, nonsurvivors were more immature (38 +/- 2 vs. 39 +/- 2 wks; p = .01), had lower birth weights (3.0 +/- 0.5 vs. 3.21 +/- 0.53 kg; p = .001), were more often prenatally diagnosed (42% vs. 32%; p = .03), were cannulated at a younger age (31 +/- 54 vs. 40 +/- 50 hrs; p = .01), and had more severe respiratory compromise (higher peak pressures and PaCO2, lower PaO2 values). Multivariate analysis showed that arterial pH and PaO2 just before ECMO, and birth weight, had the highest discriminant coefficients. By using these variables in a discriminant function (D[fx] = 0.68 x pH + 0.62 x birth weight + 0.29 x PaO2; using standardized coefficients and variables), we could identify neonates who died with a sensitivity of 62%, a specificity of 63%, a positive-predictive value of 50%, and a negative-predictive value of 74%. No single variable or combination of variables yielded better results. CONCLUSIONS Although a number of factors identify neonates with diaphragmatic hernia as being at higher risk of dying despite ECMO support, data currently collected by the neonatal Extracorporeal Life Support Organization Registry do not allow clinicians to effectively discriminate nonsurvivors from survivors.

[1]  A. Lapillonne,et al.  Preoperative stabilization using high‐frequency oscillatory ventilation in the management of congenital diaphragmatic hernia , 1994, Critical care medicine.

[2]  D. Fauza,et al.  Congenital diaphragmatic hernia and associated anomalies: their incidence, identification, and impact on prognosis. , 1994, Journal of pediatric surgery.

[3]  M. Harrison,et al.  A prospective study of the outcome for fetuses with diaphragmatic hernia. , 1994, JAMA.

[4]  P. P. O'Rourke,et al.  Congenital diaphragmatic hernia: are there reliable clinical predictors? , 1993, Critical care medicine.

[5]  P. Puri,et al.  Congenital diaphragmatic hernia: influence of associated malformations on survival. , 1993, Archives of disease in childhood.

[6]  F. Shann,et al.  Mortality Prediction in Infants with Congenital Diaphragmatic Hernia: Potential Criteria for ECMO , 1992, Anaesthesia and intensive care.

[7]  J. Atkinson,et al.  Congenital diaphragmatic hernia. Stabilization and repair on ECMO. , 1992, Annals of surgery.

[8]  W. Engle,et al.  Delayed Surgical Repair and ECMO Improves Survival in Congenital Diaphragmatic Hernia , 1992, Annals of surgery.

[9]  K. Georgeson,et al.  Improvement in survival of patients with congenital diaphragmatic hernia utilizing a strategy of delayed repair after medical and/or extracorporeal membrane oxygenation stabilization. , 1991, Journal of pediatric surgery.

[10]  K. Meurs,et al.  Extracorporeal membrane oxygenation and congenital diaphragmatic hernia: should any infant be excluded? , 1990, Journal of pediatric surgery.

[11]  R. Clark,et al.  High-frequency oscillatory ventilation and extracorporeal membrane oxygenation for the treatment of acute neonatal respiratory failure. , 1990, Pediatrics.

[12]  I. Gross,et al.  Survival of infants with persistent pulmonary hypertension without extracorporeal membrane oxygenation. , 1989, Pediatrics.

[13]  J. Wesley,et al.  Reversal of Mortality for Congenital Diaphragmatic Hernia with ECMO , 1989, Annals of surgery.

[14]  D. Kessler,et al.  ECMO: regional evaluation of need and applicability of selection criteria. , 1988, American journal of diseases of children.

[15]  J. Vacanti,et al.  Use of the postductal PaO2 as a predictor of pulmonary vascular hypoplasia in infants with congenital diaphragmatic hernia. , 1988, Journal of pediatric surgery.

[16]  R. G. Cornell,et al.  National experience with extracorporeal membrane oxygenation for newborn respiratory failure. Data from 715 cases. , 1988, ASAIO transactions.

[17]  P. Dillon,et al.  Selective use of extracorporeal membrane oxygenation in the management of congenital diaphragmatic hernia. , 1988, Journal of pediatric surgery.

[18]  D. Bohn,et al.  Ventilatory predictors of pulmonary hypoplasia in congenital diaphragmatic hernia, confirmed by morphologic assessment. , 1987, The Journal of pediatrics.

[19]  R. Bartlett,et al.  Extracorporeal Membrane Oxygenation (ECMO) in Neonatal Respiratory Failure , 1986 .

[20]  L. Greenfield,et al.  Alveolar-arterial oxygen gradients versus the Neonatal Pulmonary Insufficiency Index for prediction of mortality in ECMO candidates. , 1984, Journal of pediatric surgery.

[21]  R. Clark,et al.  Efficacy of venovenous extracorporeal membrane oxygenation for neonates with respiratory and circulatory compromise. , 1993, The Journal of pediatrics.